Tech Company Financing Transactions
Generico Funding Round
Kinsale Capital Partners and private investors participated in a $1.5 million Series A funding round for Generico. The round was announced by the company on 8/11/2015.
Transaction Overview
Company Name
Announced On
8/11/2015
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Series A
Investors
Kinsale Capital Partners (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4041 Forest Park Ave.
St. Louis, MO 63108
USA
St. Louis, MO 63108
USA
Phone
Email Address
Not Recorded
Overview
GeneriCo is a technology driven pharmaceutical company dedicated to the development of specialty generic drugs. The company is founded by industry veterans with over 100 years of combined experience in the development, manufacturing, and sales/marketing of both branded and generic pharmaceutical products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Brya
Browse more venture capital transactions:
Prev: 8/10/2015: Vasculox venture capital transaction
Next: 8/11/2015: PHEMI venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs